THE VALUE OF AFP AND HCG HALF-LIVES IN PREDICTING THE EFFICACY OF COMBINATION CHEMOTHERAPY IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS

被引：0
|
作者：
WILLEMSE, PHB
SLEIJFER, DT
KOOPS, HS
DEBRUIJN, HWA
OOSTERHUIS, JW
BROUWERS, TM
OCKHUIZEN, T
MARRINK, J
机构：
[1] STATE UNIV GRONINGEN HOSP, OBSTET & GYNAECOL LAB, GRONINGEN, NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP, IMMUNOCHEM LAB, GRONINGEN, NETHERLANDS
[3] STATE UNIV GRONINGEN HOSP, DEPT SURG ONCOL, GRONINGEN, NETHERLANDS
[4] STATE UNIV GRONINGEN HOSP, DEPT PATHOL, GRONINGEN, NETHERLANDS
来源：
ONCODEVELOPMENTAL BIOLOGY AND MEDICINE | 1981年 / 2卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 134
页数：6
相关论文
共 50 条
  • [41] Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
    Massard, C.
    Kramar, A.
    Beyer, J.
    Hartmann, J. T.
    Lorch, A.
    Pico, J. L.
    Rosti, G.
    Droz, J. P.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 322 - 328
  • [42] ORCHIDECTOMY ALONE IN TESTICULAR STAGE-I NON-SEMINOMATOUS GERM-CELL TUMORS
    PECKHAM, MJ
    HUSBAND, JE
    BARRETT, A
    HENDRY, WF
    LANCET, 1982, 2 (8300): : 678 - 680
  • [43] PRIMARY MALIGNANT NON-SEMINOMATOUS GERM-CELL TUMOR OF THE MEDIASTINUM TREATED BY SURGERY AND CHEMOTHERAPY
    WHELAN, AJ
    HUGHES, CF
    FLYNN, PWP
    PAGE, JP
    RUTLAND, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1988, 58 (03): : 251 - 254
  • [44] SINGLE AGENT ACTIVITY OF METHOTREXATE IN ADVANCED NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS
    SMITH, DB
    RUSTIN, GJS
    HITCHINS, R
    BAGSHAWE, KD
    HOSKINS, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11): : 1779 - 1781
  • [45] ORCHIDECTOMY ALONE IN TESTICULAR STAGE-I NON-SEMINOMATOUS GERM-CELL TUMORS
    LEIBUNDGUT, U
    BIEDERMANN, C
    LANDMANN, C
    OBRECHT, JP
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (23) : 820 - 826
  • [46] DISEASE RELAPSE IN PATIENTS WITH STAGE-I NON-SEMINOMATOUS GERM-CELL TUMOR OF THE TESTIS ON ACTIVE SURVEILLANCE
    THOMPSON, PI
    HARVEY, VJ
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 269 - 269
  • [47] Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors
    Inanc, SE
    Meral, R
    Darendeliler, E
    Yasasever, V
    Onat, H
    ACTA ONCOLOGICA, 1999, 38 (04) : 505 - 509
  • [48] Clinical evaluation of Olympus AFP assay as an aid in the management of patients with non-seminomatous germ cell tumors (NSGCT)
    Shah, H.
    Rush, C.
    Minihan, M.
    Kenny, P.
    Davis, D.
    Loebel, J.
    Lepp, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A112
  • [49] Experience of discordant βhCG results by different assays in the management of non-seminomatous germ cell tumours of the testis
    Summers, J
    Raggatt, P
    Pratt, J
    Williams, MV
    CLINICAL ONCOLOGY, 1999, 11 (06) : 388 - 392
  • [50] Clinical outcomes in patients with post-chemotherapy residual non-retroperitoneal (RP) disease in non-seminomatous germ-cell tumors (NSGCT)
    King, Jennifer
    Ashkar, Ryan
    Kesler, Kenneth
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345